Recombinant Human GPR107 Protein ，His & Myc

GPR107 is an orphan G protein-coupled receptor (GPCR) that has garnered interest in recent years due to its potential roles in various physiological processes and disease states. As a member of the GPCR superfamily, GPR107 is characterized by its unique structure, which includes seven transmembrane domains, a hallmark of GPCRs that facilitates signal transduction across cell membranes. The receptor is known to be involved in cellular responses to ligands, but its exact physiological function remains largely elusive, leading to a growing demand for research to elucidate its role in human health and disease. Emerging studies suggest that GPR107 may play a part in tumor biology, neurobiology, and metabolic processes, making it a candidate for therapeutic targeting in a range of conditions such as cancer and neurodegenerative diseases. Given the complexity of GPCR signaling and the potential implications of GPR107 in pathological conditions, the production of recombinant GPR107 protein is essential for functional assays, structural studies, and drug discovery efforts. Understanding the receptor's ligand-binding properties and downstream signaling pathways through the use of its recombinant form will enhance our knowledge of GPR107's role in cellular communication and open new avenues for developing targeted therapies. Advances in recombinant protein technology enable the generation of purified GPR107 for high-throughput screening and structural analysis, ultimately contributing to the broader field of GPCR research and personalized medicine.